We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.9B
AUM Growth
+$317M
Cap. Flow
-$92.4M
Cap. Flow %
-1.56%
Top 10 Hldgs %
47.94%
Holding
165
New
49
Increased
48
Reduced
28
Closed
27

Top Sells

Rank Stock Value
1
CPB icon
Campbell Soup
CPB
+$59.8M
2
LULU icon
lululemon athletica
LULU
+$56.9M
3
AMZN icon
Amazon
AMZN
+$46.6M
4
TH icon
Target Hospitality
TH
+$46.3M
5
ALKS icon
Alkermes
ALKS
+$43.6M

Sector Composition

Rank Sector Weight
1 Healthcare 44.61%
2 Consumer Discretionary 7.96%
3 Consumer Staples 6.71%
4 Communication Services 3.41%
5 Technology 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNST icon
101
The Honest Company
HNST
$428M
$7.18M 0.12%
+692,000
New +$8.45M
VSTM icon
102
Verastem
VSTM
$511M
$6.16M 0.1%
+166,667
New +$6.12M
TBIO
103
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$5.97M 0.1%
29,778
+18,667
+168% +$4.74M
XTIA icon
104
XTI Aerospace
XTIA
$59.6M
$5.84M 0.1%
+4
New +$7.51M
CYRN
105
DELISTED
CYREN Ltd.
CYRN
$5.21M 0.09%
+416,667
New +$4.89M
CLRO icon
106
ClearOne Inc
CLRO
$10.8M
$5.11M 0.09%
+144,928
New +$5.65M
PTON icon
107
Peloton Interactive
PTON
$2.86B
$4.88M 0.08%
+56,000
New +$6.19M
TELA icon
108
TELA Bio
TELA
$40.6M
$4.75M 0.08%
348,000
+84,000
+32% +$1.17M
MARK
109
DELISTED
Remark Holdings, Inc.
MARK
$4.45M 0.08%
+423,729
New +$5.55M
OUT icon
110
Outfront Media
OUT
$5.63B
$4.43M 0.08%
+178,812
New +$4.22M
ARDS
111
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$3.93M 0.07%
+1,068,444
New +$4.94M
TENX icon
112
Tenax Therapeutics
TENX
$517M
$3.58M 0.06%
1,262
PIXY
113
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$3.16M 0.05%
+79
New +$4.57M
INDP icon
114
Indaptus Therapeutics
INDP
$181M
$2.99M 0.05%
+13,639
New +$3.94M
TPR icon
115
Tapestry
TPR
$31.5B
$2.59M 0.04%
+70,000
New +$2.88M
RVPH
116
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$2.57M 0.04%
31,535
-4,200
-12% -$331K
BCTXW
117
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$1.78M 0.03%
375,000
TOMZ icon
118
TOMI Environmental Solutions
TOMZ
$14.9M
$1.76M 0.03%
+430,333
New +$2.79M
HURA
119
TuHURA Biosciences
HURA
$133M
$1.75M 0.03%
+1,163
New +$3.05M
NERV icon
120
Minerva Neurosciences
NERV
$188M
$1.74M 0.03%
125,000
+11,000
+10% +$165K
CANF
121
Can-Fite BioPharma American Depositary Shares
CANF
$6.83M
$1.45M 0.02%
+4,375
New +$1.72M
XBIO icon
122
Xenetic Biosciences
XBIO
$6.44M
$1.19M 0.02%
+57,800
New +$1.58M
INM icon
123
InMed Pharmaceuticals
INM
$7.96M
$893K 0.02%
1,020
-760
-43% -$906K
KTTAW icon
124
Pasithea Therapeutics Warrants
KTTAW
$24.1K
$800K 0.01%
+1,000,000
New +$780K
GROMW
125
DELISTED
Grom Social Enterprises Inc. Warrants
GROMW
$795K 0.01%
24,100

Similar funds

Armistice Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Armistice Capital held 165 positions worth $5.9B, up 5.7% from $5.59B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Armistice Capital's Q3 2021 filing shows 49 new, 48 increased, 28 reduced and 27 closed positions. Its largest new stake was Five Below: 381,266 shares worth $67.4M. The largest sale was Campbell Soup, an estimated $59.8M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 44% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q3 2021 buy was Five Below: 381,266 shares worth $67.4M.
  • Armistice Capital added most to Incyte in Q3 2021, an estimated $107M increase.
  • Armistice Capital's biggest Q3 2021 reduction was Amazon, cutting an estimated $46.6M.
  • Armistice Capital fully exited Campbell Soup in Q3 2021, selling an estimated $59.8M.
  • Armistice Capital's ten largest holdings make up 48% of its $5.9B portfolio in Q3 2021.
  • Armistice Capital opened 49 new positions and closed 27 in Q3 2021.
  • Armistice Capital's portfolio value rose 5.7% quarter-over-quarter to $5.9B.

Based on Armistice Capital's 13F filing for Q3 2021, filed 15 Nov 2021.